The hepatorenal protective effects of silymarin in cancer patients receiving chemotherapy: a randomized, placebo-controlled trial.
- 2024-09-04
- RCT · n = 100
- BMC complementary medicine and therapies 24(1)
- Safoora Sadat Erfanian
- Hourieh Ansari
- Shaghayegh Haghjooy Javanmard
- Zahra Amini
- Ali Hajigholami
- PubMed: 39232773
- DOI: 10.1186/s12906-024-04627-7
4 Insights on
- High evidence
- Large Human Trial